Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT07203118
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-02
First Post:
2025-09-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
Sponsor:
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-15
First Submit QC Date:
None
Study First Post Date:
2025-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-23
Last Update Post Date:
2025-10-02
Last Update Post Date Type:
ESTIMATED